Published in Can J Physiol Pharmacol on November 01, 1987
Effect of ethanol on CHCl3 metabolism in hepatic microsomes from Osborne-Mendel rats. Environ Health Perspect (1994) 0.75
Chemicals, drugs, and lipid peroxidation. Annu Rev Pharmacol Toxicol (1976) 1.45
Studies on the mechanism of phenobarbital-enhanced sulfobromophthalein disappearance. J Pharmacol Exp Ther (1968) 1.37
Intrahepatic cholestasis induced by drugs and chemicals. Pharmacol Rev (1976) 1.21
Comparison of the biochemical alterations elicited in livers from rats treated with carbon tetrachloride, chloroform, 1,1,2-trichloroethane and 1,1,1-trichloroethane. Biochem Pharmacol (1969) 1.20
Effect of phenobarbital on the excretion of an exogenous bilirubin load. Biochem Pharmacol (1967) 1.14
Chlorinated hydrocarbon toxicity. Potentiation by isopropyl alcohol and acetone. Arch Environ Health (1974) 1.14
Maximum biliary excretion of bilirubin and sulfobromophthalein during anesthesia-induced alteration of rectal temperature. Proc Soc Exp Biol Med (1967) 1.07
Hepatic subcellular distribution of manganese in manganese and manganese-bilirubin induced cholestasis. Biochem Pharmacol (1985) 1.07
Differences in the potentiation of carbon tetrachloride in rats by ethanol and isopropanol pretreatment. Toxicol Appl Pharmacol (1971) 1.06
Evidence that periodontal pressoreceptors provide positive feedback to jaw closing muscles during mastication. J Neurophysiol (1987) 0.98
Plasma disappearance and biliary excretion of indocyanine green in rats, rabbits, and dogs. Toxicol Appl Pharmacol (1969) 0.98
Relative effects of various chlorinated hydrocarbons on liver and kidney function in mice. Toxicol Appl Pharmacol (1966) 0.97
Relationship of alcohol metabolism to the potentiation of CCl 4 hepatotoxicity induced by aliphatic alcohols. J Pharmacol Exp Ther (1972) 0.97
Functional changes of the biliary tree associated with experimentally induced cholestasis: sulfobromophthalein on manganese-bilirubin combinations. Toxicol Appl Pharmacol (1991) 0.97
The nature of alpha-naphthylisothiocyanate-induced cholestasis. Toxicol Appl Pharmacol (1965) 0.96
Species variation in metabolism, storage, and excretion of sulfobromophthalein. Am J Physiol (1967) 0.94
Relative effects of various chlorinated hydrocarbons on liver and kidney function in dogs. Toxicol Appl Pharmacol (1967) 0.92
Alteration of the plasma disappearance and biliary excretion patterns of exogenously administered bilirubin by alpha-nephthylisothiocyanate. J Pharmacol Exp Ther (1967) 0.91
Maximal biliary excretion of bilirubin and sulfobromophthalein during various rates of infusion in rats of different weights and strains. Toxicol Appl Pharmacol (1969) 0.90
Effect of simultaneous exposure to toluene and xylene on their respective biological exposure indices in humans. Int Arch Occup Environ Health (1991) 0.89
Acute alteration of chloroform-induced hepato- and nephrotoxicity by n-hexane, methyl n-butyl ketone, and 2,5-hexanedione. Toxicol Appl Pharmacol (1980) 0.88
Determination of sulfobromophthalein storage and exertory rate in small animals. J Appl Physiol (1967) 0.88
Mastication in the rabbit: a description of movement and muscle activity. J Neurophysiol (1989) 0.87
Effect of halogenated hydrocarbons on organic ion accumulation by renal cortical slices of rats and mice. Toxicol Appl Pharmacol (1972) 0.85
alpha-Naphthylisothiocyanate (ANIT) hepatotoxicity and irreversible binding to rat liver microsomes. Biochem Pharmacol (1977) 0.84
Potentiation of thioacetamide-induced hepatotoxicity in alloxan- and streptozotocin-diabetic rats. Toxicol Lett (1983) 0.83
Pathogenesis of lithocholate-induced intrahepatic cholestasis: role of glucuronidation and hydroxylation of lithocholate. Biochim Biophys Acta (1992) 0.83
Isopropanol and acetone potentiation of carbon tetrachloride-induced hepatotoxicity: single versus repetitive pretreatments in rats. J Toxicol Environ Health (1982) 0.83
Acute toxicity of antiepileptic drugs. Epilepsia (1975) 0.82
Correlation between acetone-potentiated CCl4-induced liver injury and blood concentrations after inhalation or oral administration. Toxicol Appl Pharmacol (1986) 0.82
Quantitative and temporal delineation of various parameters of liver dysfunction due to alpha-naphthylisothiocyanate. Toxicol Appl Pharmacol (1965) 0.81
Monohydroxy bile acid induced cholestasis: role of biotransformation. Drug Metab Rev (1997) 0.81
Potentiation and inhibition of alpha-naphthylisothiocyanate-induced hyperbilirubinemia and cholestasis. J Pharmacol Exp Ther (1965) 0.80
Catecholamine potentiation of carbon tetrachloride-induced hepatotoxicity in mice. Toxicol Appl Pharmacol (1969) 0.80
The effect of SKF 525A on the distribution of carbon tetrachloride in rats. J Pharmacol Exp Ther (1970) 0.80
Reduced bile flow after sulfobromophthalein administration in the rat. Proc Soc Exp Biol Med (1970) 0.80
Effect of dosing vehicle on the hepatotoxicity of CCl4 and nephrotoxicity of CHCl3 in rats. J Toxicol Environ Health (1997) 0.80
Rat hepatocytes with elevated metallothionein expression are resistant to N-methyl-N'-nitro-N-nitrosoguanidine cytotoxicity. Toxicol Appl Pharmacol (1996) 0.80
Functional effects of -naphthylisothiocyanate in various species. Toxicol Appl Pharmacol (1971) 0.80
Relationship between the carbon skeleton length of ketonic solvents and potentiation of chloroform-induced hepatotoxicity in rats. Toxicol Lett (1983) 0.80
Protection by 2-diethylaminoethyl-2,2-diphenylvalerate hydrochloride against carbon tetrachloride hepatotoxicity. A possible mechanism of action. Biochem Pharmacol (1971) 0.79
Functional aspects of the cholestatic response induced by -naphthylisothiocyanate in mice and rats. Agents Actions (1969) 0.79
Sulfobromophthalein metabolism and excretion in rats with iodomethane-induced depletion of hepatic glutathione. J Pharmacol Exp Ther (1970) 0.79
Acetone-induced potentiation of trihalomethane toxicity in male rats. Toxicol Lett (1983) 0.79
Extrarenal excretion of drugs and chemicals. Annu Rev Pharmacol (1968) 0.79
Modification of haloalkane-induced hepatotoxicity by exogenous ketones and metabolic ketosis. Fed Proc (1980) 0.79
Temporal aspects of carbon tetrachloride-induced alteration of sulfobromophthalein excretion and metabolism. Toxicol Appl Pharmacol (1970) 0.79
Evaluation of health aspects of GRAS food ingredients: lessons learned and questions unanswered. Fed Proc (1977) 0.79
Potentiation of the hepatotoxic responses to chemicals in alloxan-diabetic rats. Proc Soc Exp Biol Med (1975) 0.78
Effect of norethandrolone, acetohexamide, and Enovid on alpha-naphthylisothiocyanate-induced hyperbilirubinemia and cholestasis. Biochem Pharmacol (1966) 0.78
Ketone potentiation of haloalkane-induced hepato- and nephrotoxicity. II. Implication of monooxygenases. J Toxicol Environ Health (1995) 0.78
Biochemical and morphological parameters of taurolithocholate-induced cholestasis. Can J Physiol Pharmacol (1971) 0.78
Dose-dependent modification of 1,1-dichloroethylene toxicity by acetone. Toxicol Lett (1983) 0.78
The nephrotoxicity of single and multiple doses of aliphatic chlorinated hydrocarbon solvents in male mice. Toxicol Appl Pharmacol (1972) 0.77
Potentiation of carbon tetrachloride-induced hepatotoxicity in alloxan- or strepto- zotocin-diabetic rats. J Pharmacol Exp Ther (1975) 0.77
Effect of aminotriazole on isopropanol- and acetone-induced potentiation of CCl 4 hepatotoxicity. Can J Physiol Pharmacol (1973) 0.77
Methyl isobutyl ketone metabolites and potentiation of the cholestasis induced in rats by a manganese-bilirubin combination or manganese alone. Toxicol Appl Pharmacol (1988) 0.77
Studies on bilirubin production and excretion in mice and rats treated with phenobarbital, chlorpromazine, norethandrolone, acetohexamide or enovid. Toxicol Appl Pharmacol (1969) 0.77
Ketone potentiation of haloalkane-induced hepato- and nephrotoxicity. I. Dose-response relationships. J Toxicol Environ Health (1995) 0.77
Phenobarbitone and biliary excretion. Lancet (1968) 0.77
Metabolic fate of methyl n-butyl ketone, methyl isobutyl ketone and their metabolites in mice. Toxicol Lett (1994) 0.77
Effects of acetone and methyl n-butyl ketone on hepatic mixed-function oxidase. Biochem Pharmacol (1989) 0.77
Potentiation of chloroform-induced hepatotoxicity by methyl isobutyl ketone and two metabolites. Can J Physiol Pharmacol (1990) 0.77
Hemodynamic effects of CCl4 in the intact liver of the cat. Can J Physiol Pharmacol (1974) 0.77
Measurement of hepatic blood flow by a thermodilution method. J Appl Physiol (1967) 0.77
Phase I and phase II metabolism of lithocholic acid in hepatic acinar zone 3 necrosis. Evaluation in rats by combined radiochromatography and gas-liquid chromatography-mass spectrometry. Biochem Pharmacol (1994) 0.77
Tissue concentrations of methyl isobutyl ketone, methyl n-butyl ketone and their metabolites after oral or inhalation exposure. Toxicol Lett (1995) 0.77
Induction of metallothionein gene expression by epidermal growth factor and its inhibition by transforming growth factor-beta and dexamethasone in rat hepatocytes. Hepatology (1995) 0.77
Role of perivenous hepatocytes in taurolithocholate-induced cholestasis in vivo. Toxicol Lett (2000) 0.77
Acute alteration of chloroform-induced hepato- and nephrotoxicity by Mirex and Kepone. Toxicol Appl Pharmacol (1979) 0.76
Evidence for the involvement of organelles in the mechanism of ketone-potentiated chloroform-induced hepatotoxicity. Liver (1990) 0.76
Taurolithocholate-induced intrahepatic cholestasis: potentiation by methyl isobutyl ketone and methyl n-butyl ketone in rats. Toxicol Appl Pharmacol (1985) 0.76
Effects of benziodarone on the metabolism and biliary excretion of sulfobromophthalein and related dyes. Proc Soc Exp Biol Med (1969) 0.76
Role of the enterohepatic circulation in the elimination of phenytoin in the rat. Drug Metab Dispos (1978) 0.76
The role of acinar zone 3 hepatocytes in bile formation: influence of bromobenzene treatment on bile formation in the rat. Liver (1990) 0.76
Morphological aspects of manganese-bilirubin induced cholestasis. Liver (1982) 0.75
Influence of various mixtures of inhaled toluene and xylene on the biological monitoring of exposure to these solvents in rats. Can J Physiol Pharmacol (1992) 0.75
Quantitative aspects in the assessment of liver injury. Environ Health Perspect (1976) 0.75
Assessment of liver function in mice. Lab Anim Care (1967) 0.75
Susceptibility of male and female mice to the nephrotoxic and hepatotoxic properties of chlorinated hydrocarbons. Proc Soc Exp Biol Med (1967) 0.75
Demonstration of bile stasis in the mouse by a direct and an indirect method. J Appl Physiol (1965) 0.75
Plasma concentrations in methyl isobutyl ketone-potentiated experimental cholestasis after inhalation or oral administration. Fundam Appl Toxicol (1993) 0.75
Computer-aided design in wheelchair seating. J Rehabil Res Dev (1989) 0.75
Altered cholesterol synthesis as a mechanism involved in methyl isobutyl ketone-potentiated experimental cholestasis. Toxicol Appl Pharmacol (1997) 0.75
Activity during mastication of periodontal mechanosensitive neurons of the trigeminal subnucleus oralis of the rabbit. J Neurophysiol (1988) 0.75
The flexible contour backrest: a new design concept for wheelchairs. Assist Technol (1998) 0.75
Alteration of lipid composition of hepatic membranes associated with manganese-bilirubin induced cholestasis. Fundam Clin Pharmacol (1998) 0.75
Patterns of liver injury induced by mixtures of halogenated hydrocarbons: a predictable event? Drug Metab Rev (1997) 0.75
Chloral hydrate enhances ethanol-induced inhibition of methanol oxidation in mice. Toxicology (1998) 0.75
Dose- and route-dependent alteration of metabolism and toxicity of chloroform in fed and fasting rats. Toxicol Appl Pharmacol (1995) 0.75
Hepatotoxicity of alpha-naphthylisothiocyanate congeners with particular emphasis on phenylisothiocyanate. Toxicol Appl Pharmacol (1965) 0.75
[Training of interviewers in the utilization of standardized questionnaires in psychiatry: studies realized with the Present State Examination (PSE)]. Acta Psychiatr Belg (1994) 0.75
The effect of bile duct ligation, bile duct cannulation, and hypothermia on alpha-naphthylisothiocyanate-induced hyperbilirubinemia and cholestasis in rats. Gastroenterology (1966) 0.75
Influence of agents affecting monooxygenase activity on taurolithocholic acid-induced cholestasis. Toxicol Lett (1992) 0.75
1-Naphthyl isocyanate and 1-naphthylamine as metabolites of 1-naphthylisothiocyanate. Liver (1995) 0.75
Manganese-bilirubin effect on cholesterol accumulation in rat bile canalicular membranes. Toxicol Sci (2000) 0.75
Ketone potentiation of haloalkane-induced hepatotoxicity: CCl4 and ketone treatment on hepatic membrane integrity. J Toxicol Environ Health (1996) 0.75
Ketone potentiation of intrahepatic cholestasis: effect of two aliphatic isomers. J Toxicol Environ Health (1997) 0.75
Pharmacodynamic and metabolic interactions between ethanol and two industrial solvents (methyl n-butyl ketone and methyl isobutyl ketone) and their principal metabolites in mice. Toxicology (1995) 0.75
1,3-Butanediol pretreatment on the cholestasis induced in rats by manganese--bilirubin combination, taurolithocholic acid, or alpha-naphthylisothiocyanate. Toxicol Appl Pharmacol (1981) 0.75